Cargando…
Tetrandrine Treatment May Improve Clinical Outcome in Patients with COVID-19
Background and objectives: The COVID-19 pandemic continues worldwide, and there is no effective treatment to treat it. Chinese medicine is considered the recommended treatment for COVID-19 in China. This study aimed to examine the effectiveness of tetrandrine in treating COVID-19, which is originall...
Autores principales: | Chen, Shiyin, Liu, Yiran, Ge, Juan, Yin, Jianzhong, Shi, Ting, Ntambara, James, Cheng, Zhounan, Chu, Minjie, Gu, Hongyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503147/ https://www.ncbi.nlm.nih.gov/pubmed/36143871 http://dx.doi.org/10.3390/medicina58091194 |
Ejemplares similares
-
Optimum birth interval (36–48 months) may reduce the risk of undernutrition in children: A meta-analysis
por: Ntambara, James, et al.
Publicado: (2023) -
The risk to child nutrition during and after COVID-19 pandemic: what to expect and how to respond
por: Ntambara, James, et al.
Publicado: (2021) -
Tetrandrine Attenuated Doxorubicin-Induced Acute Cardiac Injury in Mice
por: Li, Gang, et al.
Publicado: (2020) -
Neuroprotective effects of tetrandrine against vascular dementia
por: Lv, Yan-ling, et al.
Publicado: (2016) -
Tetrandrine Derivatives
as Promising Antibacterial
Agents
por: Calvillo-Páez, Viviana I., et al.
Publicado: (2023)